CSL PHARMA-ADVICE ApS: Financial statements 2019
CVR: 36501693
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CSL PHARMA-ADVICE ApS (CVR 36501693) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 261,334 and a net result of DKK 134,580 compared with DKK 214,343 the year before. That is a decrease of 34.6% compared with the year before. The profit margin was 51.5%. Equity in the 2019 report amounted to DKK 480,199. The solvency ratio was 86.4%.
- Revenue
- DKK 261,334
- Gross Profit
- DKK 180,521
- Profit/Loss
- DKK 134,580
- Equity
- DKK 480,199
- Total Assets
- DKK 555,597
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 261 t. | 181 t. | 135 t. | 480 t. | - |
| 2018 | 400 t. | 281 t. | 214 t. | 546 t. | - |
| 2017 | 404 t. | 337 t. | 262 t. | 571 t. | - |
| 2016 | 249 t. | 189 t. | 145 t. | 309 t. | - |
| 2015 | 155 t. | 151 t. | 114 t. | 164 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CSL PHARMA-ADVICE ApS has published its annual report for 2018. Revenue came to DKK 399,613, and the net result was DKK 214,343.
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS was a Danish company of the type Anpartsselskab based in Lejre, founded in 2015. The company has been dissolved on 4 January 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890.